Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's hepatitis scourge tackled in joint venture:

This article was originally published in Clinica

Executive Summary

The diagnosis of viral hepatitis, one of China's major public health problems, is to be tackled by a joint venture between the Chinese and Australian governments. More than US$1.1 million will be invested in upgrading the equipment at Beijing Biochemical and Immune Reagents Centre. The aim is to make it a reference centre for hepatitis diagnosis within two and a half years. China has at least 160 million hepatitis virus carriers and the disease has the highest mortality and incidence rates of all infectious diseases in the country.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT085152

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel